Here, our studies provide several pieces of evidence that together indicate that a p38γ-activated ternary-complex with Hsp90 and K-Ras may be a novel therapeutic target for K-Ras dependent colon cancer. This evidence concerns the gene KRAS and colonic neoplasm.